145 related articles for article (PubMed ID: 38611800)
1. 4-Chloroisocoumarins as Chlamydial Protease Inhibitors and Anti-Chlamydial Agents.
Phillips MJA; Huston WM; McDonagh AM; Rawling T
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611800
[TBL] [Abstract][Full Text] [Related]
2. Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors.
Harper JW; Powers JC
Biochemistry; 1985 Dec; 24(25):7200-13. PubMed ID: 3910097
[TBL] [Abstract][Full Text] [Related]
3. Coumarin and isocoumarin as serine protease inhibitors.
Pochet L; Frédérick R; Masereel B
Curr Pharm Des; 2004; 10(30):3781-96. PubMed ID: 15579071
[TBL] [Abstract][Full Text] [Related]
4. Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.
Prusty BK; Chowdhury SR; Gulve N; Rudel T
Front Cell Infect Microbiol; 2018; 8():183. PubMed ID: 29900129
[TBL] [Abstract][Full Text] [Related]
5. Chlamydial-Secreted Protease Chlamydia High Temperature Requirement Protein A (cHtrA) Degrades Human Cathelicidin LL-37 and Suppresses Its Anti-Chlamydial Activity.
Dong X; Zhang W; Hou J; Ma M; Zhu C; Wang H; Hou S
Med Sci Monit; 2020 Jul; 26():e923909. PubMed ID: 32634134
[TBL] [Abstract][Full Text] [Related]
6. A Novel Cleavage Pattern of Complement C5 Induced by
Peng L; Gao J; Hu Z; Zhang H; Tang L; Wang F; Cui L; Liu S; Zhao Y; Xu H; Su X; Feng X; Fang Y; Chen J
Front Cell Infect Microbiol; 2021; 11():732163. PubMed ID: 35087765
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
[TBL] [Abstract][Full Text] [Related]
8. Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues.
Hwang J; Strange N; Phillips MJA; Krause AL; Heywood A; Gamble AB; Huston WM; Tyndall JDA
Eur J Med Chem; 2021 Nov; 224():113692. PubMed ID: 34265463
[TBL] [Abstract][Full Text] [Related]
9. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.
Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC
Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526
[TBL] [Abstract][Full Text] [Related]
10. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor.
Harper JW; Hemmi K; Powers JC
Biochemistry; 1985 Apr; 24(8):1831-41. PubMed ID: 3893537
[TBL] [Abstract][Full Text] [Related]
11. The protease inhibitor JO146 demonstrates a critical role for CtHtrA for Chlamydia trachomatis reversion from penicillin persistence.
Ong VA; Marsh JW; Lawrence A; Allan JA; Timms P; Huston WM
Front Cell Infect Microbiol; 2013; 3():100. PubMed ID: 24392355
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based isocoumarin inhibitors for human leukocyte elastase. Effect of the 7-amino substituent and 3-alkoxy group in 3-alkoxy-7-amino-4-chloroisocoumarins on inhibitory potency.
Kerrigan JE; Oleksyszyn J; Kam CM; Selzler J; Powers JC
J Med Chem; 1995 Feb; 38(3):544-52. PubMed ID: 7853347
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of a putative serine protease contributing to the γ-secretase cleavage of β-amyloid precursor protein.
Peuchmaur M; Lacour MA; Sévalle J; Lisowski V; Touati-Jallabe Y; Rodier F; Martinez J; Checler F; Hernandez JF
Bioorg Med Chem; 2013 Feb; 21(4):1018-29. PubMed ID: 23294826
[TBL] [Abstract][Full Text] [Related]
14. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis.
Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y
Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460
[TBL] [Abstract][Full Text] [Related]
15. The ClpX and ClpP2 Orthologs of Chlamydia trachomatis Perform Discrete and Essential Functions in Organism Growth and Development.
Wood NA; Blocker AM; Seleem MA; Conda-Sheridan M; Fisher DJ; Ouellette SP
mBio; 2020 Sep; 11(5):. PubMed ID: 32873765
[No Abstract] [Full Text] [Related]
16. The chlamydial EUO gene encodes a histone H1-specific protease.
Kaul R; Hoang A; Yau P; Bradbury EM; Wenman WM
J Bacteriol; 1997 Sep; 179(18):5928-34. PubMed ID: 9294454
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design.
Powers JC; Kam CM; Narasimhan L; Oleksyszyn J; Hernandez MA; Ueda T
J Cell Biochem; 1989 Jan; 39(1):33-46. PubMed ID: 2654146
[TBL] [Abstract][Full Text] [Related]
18. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
[TBL] [Abstract][Full Text] [Related]
19. CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target.
Marsh JW; Ong VA; Lott WB; Timms P; Tyndall JD; Huston WM
Future Microbiol; 2017 Jul; 12():817-829. PubMed ID: 28593794
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants.
Kam CM; Fujikawa K; Powers JC
Biochemistry; 1988 Apr; 27(7):2547-57. PubMed ID: 3164217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
